nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP19A1—osteoporosis	0.448	1	CbGaD
Masoprocol—CYP2J2—Cholecalciferol—osteoporosis	0.354	0.776	CbGbCtD
Masoprocol—CYP19A1—Raloxifene—osteoporosis	0.102	0.225	CbGbCtD
Masoprocol—IGF1R—Fulvestrant—Estradiol—osteoporosis	0.00294	1	CbGdCrCtD
Masoprocol—Dobutamine—CA2—osteoporosis	0.0013	1	CrCbGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000398	0.00434	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—LEP—osteoporosis	0.000396	0.00432	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IRS1—osteoporosis	0.000376	0.0041	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IRS1—osteoporosis	0.000366	0.004	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoporosis	0.000365	0.00398	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—IGF1—osteoporosis	0.000365	0.00398	CbGpPWpGaD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000364	0.00398	CbGpPWpGaD
Masoprocol—CYP19A1—Endogenous sterols—POMC—osteoporosis	0.00036	0.00393	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6R—osteoporosis	0.000353	0.00385	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IGF1—osteoporosis	0.000348	0.0038	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6R—osteoporosis	0.000344	0.00375	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—SOD2—osteoporosis	0.00034	0.0037	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IGF1—osteoporosis	0.000339	0.0037	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CALCR—osteoporosis	0.000334	0.00365	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PTH1R—osteoporosis	0.000334	0.00365	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000332	0.00363	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—GPX1—osteoporosis	0.000324	0.00353	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000315	0.00344	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PTH—osteoporosis	0.000311	0.00339	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6R—osteoporosis	0.00031	0.00338	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IGF1—osteoporosis	0.000305	0.00333	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CALCR—osteoporosis	0.000304	0.00331	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTH1R—osteoporosis	0.000304	0.00331	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CNR2—osteoporosis	0.000303	0.0033	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000299	0.00326	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000296	0.00323	CbGpPWpGaD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000295	0.00322	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—WNT1—osteoporosis	0.000285	0.00311	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000281	0.00306	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—TGFB1—osteoporosis	0.000272	0.00297	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00027	0.00294	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—IRS2—osteoporosis	0.000269	0.00294	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MYC—osteoporosis	0.000266	0.0029	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—MGLL—osteoporosis	0.000266	0.0029	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—CYP19A1—osteoporosis	0.000261	0.00285	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—SPP1—osteoporosis	0.00026	0.00283	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000258	0.00281	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PTHLH—osteoporosis	0.000257	0.00281	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL1B—osteoporosis	0.000252	0.00275	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000245	0.00267	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MGLL—osteoporosis	0.000241	0.00263	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000239	0.0026	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL1B—osteoporosis	0.000235	0.00257	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—IRS1—osteoporosis	0.000235	0.00257	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP27A1—osteoporosis	0.000228	0.00249	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CALCA—osteoporosis	0.000227	0.00247	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000225	0.00246	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL6—osteoporosis	0.000222	0.00242	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MYC—osteoporosis	0.000219	0.00239	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoporosis	0.000219	0.00239	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000218	0.00238	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000213	0.00232	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000206	0.00225	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000205	0.00224	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—osteoporosis	0.000204	0.00223	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoporosis	0.000204	0.00223	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SOST—osteoporosis	0.000198	0.00216	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MYC—osteoporosis	0.000196	0.00214	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TGFB1—osteoporosis	0.000196	0.00214	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000191	0.00208	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—IGF1—osteoporosis	0.00019	0.00207	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—osteoporosis	0.000183	0.002	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TGFB1—osteoporosis	0.000183	0.002	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTH1R—osteoporosis	0.000179	0.00196	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CALCR—osteoporosis	0.000179	0.00196	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL1B—osteoporosis	0.000177	0.00194	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PTH—osteoporosis	0.000176	0.00192	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CNR2—osteoporosis	0.000171	0.00187	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00017	0.00186	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SOST—osteoporosis	0.000169	0.00184	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000167	0.00183	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000162	0.00177	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTH—osteoporosis	0.000159	0.00174	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6—osteoporosis	0.000157	0.00172	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—POMC—osteoporosis	0.000157	0.00171	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000156	0.0017	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CNR2—osteoporosis	0.000155	0.0017	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—osteoporosis	0.000153	0.00167	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000153	0.00166	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTH1R—osteoporosis	0.000152	0.00166	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CALCR—osteoporosis	0.000152	0.00166	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PKM—osteoporosis	0.000148	0.00161	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—FDPS—osteoporosis	0.000148	0.00161	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—osteoporosis	0.000148	0.00161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—WNT1—osteoporosis	0.000146	0.00159	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PTHLH—osteoporosis	0.000146	0.00159	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000145	0.00158	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000145	0.00158	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MGLL—osteoporosis	0.000142	0.00155	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPD2—osteoporosis	0.00014	0.00153	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PGLS—osteoporosis	0.00014	0.00153	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LRP5—osteoporosis	0.000139	0.00152	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—osteoporosis	0.000138	0.0015	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000136	0.00148	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LRP6—osteoporosis	0.000133	0.00145	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTHLH—osteoporosis	0.000132	0.00144	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—FDPS—osteoporosis	0.000132	0.00144	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PKM—osteoporosis	0.000132	0.00144	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—osteoporosis	0.000129	0.0014	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ATIC—osteoporosis	0.000128	0.0014	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PNP—osteoporosis	0.000128	0.0014	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CALCA—osteoporosis	0.000128	0.0014	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPD2—osteoporosis	0.000125	0.00136	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PGLS—osteoporosis	0.000125	0.00136	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MGLL—osteoporosis	0.000121	0.00132	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—POMC—osteoporosis	0.000119	0.00129	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LRP5—osteoporosis	0.000118	0.00129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CALCA—osteoporosis	0.000116	0.00127	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ATIC—osteoporosis	0.000114	0.00125	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PNP—osteoporosis	0.000114	0.00125	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LRP6—osteoporosis	0.000113	0.00123	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000112	0.00123	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TLN1—osteoporosis	0.000112	0.00123	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00011	0.0012	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CA2—osteoporosis	0.000109	0.00119	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—OXCT1—osteoporosis	0.000109	0.00119	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MGLL—osteoporosis	0.000106	0.00116	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—osteoporosis	0.000104	0.00113	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.0001	0.00109	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—OXCT1—osteoporosis	9.72e-05	0.00106	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CA2—osteoporosis	9.72e-05	0.00106	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—P4HB—osteoporosis	9.68e-05	0.00106	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TLN1—osteoporosis	9.55e-05	0.00104	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MGLL—osteoporosis	9.48e-05	0.00103	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTH—osteoporosis	9.42e-05	0.00103	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAP1A—osteoporosis	9.26e-05	0.00101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CNR2—osteoporosis	9.18e-05	0.001	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	9.14e-05	0.000997	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADCY5—osteoporosis	9.11e-05	0.000994	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—IDH2—osteoporosis	9.04e-05	0.000986	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NFATC1—osteoporosis	9.03e-05	0.000985	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DKK1—osteoporosis	8.96e-05	0.000978	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.94e-05	0.000975	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	8.89e-05	0.00097	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.76e-05	0.000956	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—WNT1—osteoporosis	8.63e-05	0.000942	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP27A1—osteoporosis	8.5e-05	0.000927	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGA—osteoporosis	8.4e-05	0.000916	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	8.3e-05	0.000906	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADCY5—osteoporosis	8.27e-05	0.000903	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ACP5—osteoporosis	8.27e-05	0.000902	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—P4HB—osteoporosis	8.23e-05	0.000898	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.16e-05	0.000891	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—IDH2—osteoporosis	8.06e-05	0.000879	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTH—osteoporosis	8.01e-05	0.000874	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAP1A—osteoporosis	7.87e-05	0.000859	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTHLH—osteoporosis	7.81e-05	0.000852	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BMP2—osteoporosis	7.81e-05	0.000852	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CNR2—osteoporosis	7.81e-05	0.000852	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TPI1—osteoporosis	7.69e-05	0.000839	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NFATC1—osteoporosis	7.68e-05	0.000838	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGB—osteoporosis	7.64e-05	0.000833	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DKK1—osteoporosis	7.62e-05	0.000831	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP27A1—osteoporosis	7.58e-05	0.000827	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.45e-05	0.000813	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSMA2—osteoporosis	7.37e-05	0.000805	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSMA5—osteoporosis	7.37e-05	0.000805	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ACP5—osteoporosis	7.37e-05	0.000804	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—WNT1—osteoporosis	7.34e-05	0.000801	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.28e-05	0.000794	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—P4HB—osteoporosis	7.23e-05	0.000789	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—POMC—osteoporosis	7.2e-05	0.000786	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGA—osteoporosis	7.14e-05	0.000779	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GAPDH—osteoporosis	7.09e-05	0.000774	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—RAP1A—osteoporosis	6.91e-05	0.000754	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CALCA—osteoporosis	6.87e-05	0.00075	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TPI1—osteoporosis	6.85e-05	0.000748	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FDPS—osteoporosis	6.8e-05	0.000741	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PKM—osteoporosis	6.8e-05	0.000741	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—POMC—osteoporosis	6.7e-05	0.000731	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTHLH—osteoporosis	6.64e-05	0.000724	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BMP2—osteoporosis	6.64e-05	0.000724	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGB—osteoporosis	6.49e-05	0.000709	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PGLS—osteoporosis	6.44e-05	0.000703	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPD2—osteoporosis	6.44e-05	0.000703	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—P4HB—osteoporosis	6.44e-05	0.000703	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GAPDH—osteoporosis	6.32e-05	0.00069	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSMA2—osteoporosis	6.27e-05	0.000684	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSMA5—osteoporosis	6.27e-05	0.000684	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KL—osteoporosis	6.24e-05	0.000681	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—RAP1A—osteoporosis	6.16e-05	0.000672	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—POMC—osteoporosis	6.09e-05	0.000664	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.03e-05	0.000657	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6R—osteoporosis	5.94e-05	0.000648	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PNP—osteoporosis	5.89e-05	0.000643	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ATIC—osteoporosis	5.89e-05	0.000643	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CALCA—osteoporosis	5.84e-05	0.000637	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO1—osteoporosis	5.59e-05	0.000609	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PSMA5—osteoporosis	5.5e-05	0.0006	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PSMA2—osteoporosis	5.5e-05	0.0006	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.37e-05	0.000586	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KL—osteoporosis	5.31e-05	0.000579	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—OXCT1—osteoporosis	5.01e-05	0.000547	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA2—osteoporosis	5.01e-05	0.000547	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO1—osteoporosis	4.98e-05	0.000543	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PSMA2—osteoporosis	4.91e-05	0.000535	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PSMA5—osteoporosis	4.91e-05	0.000535	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADCY5—osteoporosis	4.89e-05	0.000533	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MGLL—osteoporosis	4.88e-05	0.000533	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SPP1—osteoporosis	4.73e-05	0.000516	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	4.62e-05	0.000504	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP19A1—osteoporosis	4.47e-05	0.000487	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS2—osteoporosis	4.28e-05	0.000467	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—osteoporosis	4.19e-05	0.000457	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADCY5—osteoporosis	4.16e-05	0.000453	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—IDH2—osteoporosis	4.15e-05	0.000453	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPP1—osteoporosis	4.02e-05	0.000439	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—osteoporosis	4e-05	0.000436	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP19A1—osteoporosis	3.98e-05	0.000434	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP27A1—osteoporosis	3.9e-05	0.000426	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ACP5—osteoporosis	3.8e-05	0.000414	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.75e-05	0.000409	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS1—osteoporosis	3.73e-05	0.000407	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADCY5—osteoporosis	3.65e-05	0.000398	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS2—osteoporosis	3.64e-05	0.000397	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—osteoporosis	3.64e-05	0.000397	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—osteoporosis	3.6e-05	0.000392	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—osteoporosis	3.56e-05	0.000388	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TPI1—osteoporosis	3.53e-05	0.000385	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6R—osteoporosis	3.51e-05	0.000383	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—osteoporosis	3.46e-05	0.000377	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—osteoporosis	3.4e-05	0.000371	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—osteoporosis	3.36e-05	0.000366	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—P4HB—osteoporosis	3.32e-05	0.000362	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GAPDH—osteoporosis	3.26e-05	0.000355	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADCY5—osteoporosis	3.25e-05	0.000355	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—osteoporosis	3.24e-05	0.000354	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS1—osteoporosis	3.17e-05	0.000346	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—RAP1A—osteoporosis	3.17e-05	0.000346	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—osteoporosis	3.06e-05	0.000334	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—osteoporosis	2.99e-05	0.000326	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6R—osteoporosis	2.98e-05	0.000325	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—osteoporosis	2.94e-05	0.000321	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-05	0.000302	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—osteoporosis	2.68e-05	0.000293	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—osteoporosis	2.64e-05	0.000289	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO1—osteoporosis	2.56e-05	0.00028	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PSMA2—osteoporosis	2.53e-05	0.000276	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PSMA5—osteoporosis	2.53e-05	0.000276	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—osteoporosis	2.39e-05	0.000261	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—osteoporosis	2.08e-05	0.000227	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—osteoporosis	2.07e-05	0.000226	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—osteoporosis	1.77e-05	0.000193	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—osteoporosis	1.76e-05	0.000192	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000183	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—osteoporosis	1.67e-05	0.000182	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—osteoporosis	1.56e-05	0.00017	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—osteoporosis	1.54e-05	0.000168	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—osteoporosis	1.33e-05	0.000145	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—osteoporosis	1.23e-05	0.000134	CbGpPWpGaD
